Prices delayed by at least 15 minutes | Print
Ovoca Bio PLC (OVB)
EUR0.125 (CDI)Open
1.275p
Previous close
1.25p
Trade high
1.2875p
Volume
311,544
Year high
1.98p
Year low
0.65p
Dividend yield
–
Market capitalisation
£1.04 mn
P/E ratio
–
ISIN
IE00B4XVDC01
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX- Libicore - a novel synthetic peptide, administrated through a nasal spray.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 24/04/2025 | 02:32:30 | 1.2875 | 130,000 | 1,673.75 |
| 24/04/2025 | 01:31:00 | 1.275 | 69,230 | 882.68 |
| 24/04/2025 | 09:31:46 | 1.275 | 112,314 | 1,432.00 |
| 17/04/2025 | 11:33:04 | 1.289 | 77 | 0.99 |
| 16/04/2025 | 09:13:23 | 1.141 | 126,051 | 1,438.24 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.